Benjamin A. H. Smith

Employment

• Stanford University School of Medicine

Education

• Pomona College
• Stanford University

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
  Discover Mental Health 2023 DOI: 10.1007/s44192-023-00050-5
  +Save
• MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
  Proceedings of the National Academy of Sciences 2023 DOI: 10.1073/pnas.2215376120
  +Save
• Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma.
  2022
  +Save
• Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma.
  2022
  +Save
• Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
  2022 DOI: 10.21203/rs.3.rs-2086278/v1
  +Save
• Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
  Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton +23 more
  Nature cancer 2022 DOI: 10.1038/s43018-022-00405-x
  +Save
• Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
  Johanna Lena Theruvath, Marie J. Menard, Benjamin A. H. Smith +39 more
  Nature Medicine 2022 DOI: 10.1038/s41591-021-01625-x
  +Save
• Small RNAs are modified with N-glycans and displayed on the surface of living cells
  Cell 2021 DOI: 10.1016/j.cell.2021.04.023
  +Save
• Author Correction: The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
  Nature Reviews Drug Discovery 2021 DOI: 10.1038/s41573-021-00160-1
  +Save
• The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
  Nature Reviews Drug Discovery 2021 DOI: 10.1038/s41573-020-00093-1
  +Save
• Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
  Proceedings of the National Academy of Sciences 2021 DOI: 10.1073/pnas.2015024118
  +Save
• GD2 is a macrophage checkpoint molecule and combined GD2/CD47 blockade results in synergistic effects and tumor clearance in xenograft models of neuroblastoma and osteosarcoma
  2020
  +Save
• CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
  Nature Chemical Biology 2019 DOI: 10.1038/s41589-019-0342-2
  +Save
• CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
  Nature 2019 DOI: 10.1038/s41586-019-1088-4
  +Save
• MicroRNA-155 deficient dendritic cells cause less severe GvHD through reduced migration and defective inflammasome activation.
  2015 DOI: 10.1182/blood-2014-12-617258
  +Save
• Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD.
  2015 DOI: 10.1182/blood-2014-06-581793
  +Save
• Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation.
  2008 DOI: 10.4049/jimmunol.181.7.4770
  +Save